|
|
|
Insider
Information: |
Malik Rajesh |
Relationship: |
|
City: |
Research Triangle Park |
State: |
NC |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
0 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$0 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
0 |
|
|
Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
7
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
7
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-7.0
|
Percentage
Gain/Loss : |
0.0%
|
-607.1%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
G1 Therapeutics Inc |
GTHX |
|
2024-09-18 |
0 |
2018-01-16 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
66 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
GTHX |
G1 Therapeutics Inc |
Chief Medical Officer |
|
2023-01-04 |
4 |
S |
$5.58 |
$9,138 |
D/D |
(1,639) |
103,468 |
0 |
% |
|
GTHX |
G1 Therapeutics Inc |
Chief Medical Officer |
|
2023-01-05 |
4 |
S |
$5.41 |
$3,942 |
D/D |
(729) |
102,739 |
0 |
% |
|
GTHX |
G1 Therapeutics Inc |
Chief Medical Officer |
|
2023-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
35,000 |
137,739 |
0 |
- |
|
GTHX |
G1 Therapeutics Inc |
Chief Medical Officer |
|
2023-07-05 |
4 |
AS |
$2.45 |
$3,339 |
D/D |
(1,361) |
136,378 |
0 |
% |
|
GTHX |
G1 Therapeutics Inc |
Chief Medical Officer |
|
2023-12-11 |
4 |
AS |
$3.06 |
$115,522 |
D/D |
(33,839) |
136,378 |
0 |
% |
|
GTHX |
G1 Therapeutics Inc |
Chief Medical Officer |
|
2023-12-11 |
4 |
OE |
$0.30 |
$12,081 |
D/D |
33,839 |
148,778 |
0 |
- |
|
GTHX |
G1 Therapeutics Inc |
Chief Medical Officer |
|
2024-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
37,300 |
173,678 |
0 |
- |
|
GTHX |
G1 Therapeutics Inc |
Chief Medical Officer |
|
2024-01-03 |
4 |
S |
$3.12 |
$9,416 |
D/D |
(3,019) |
170,659 |
0 |
% |
|
GTHX |
G1 Therapeutics Inc |
Chief Medical Officer |
|
2024-01-04 |
4 |
S |
$2.94 |
$2,121 |
D/D |
(721) |
169,938 |
0 |
% |
|
GTHX |
G1 Therapeutics Inc |
Chief Medical Officer |
|
2024-02-12 |
4 |
AS |
$4.62 |
$132,143 |
D/D |
(28,600) |
169,938 |
0 |
% |
|
GTHX |
G1 Therapeutics Inc |
Chief Medical Officer |
|
2024-02-12 |
4 |
OE |
$0.30 |
$8,580 |
D/D |
28,600 |
198,538 |
0 |
- |
|
GTHX |
G1 Therapeutics Inc |
Chief Medical Officer |
|
2024-05-13 |
4 |
S |
$4.79 |
$39,034 |
D/D |
(8,151) |
161,787 |
0 |
% |
|
GTHX |
G1 Therapeutics Inc |
Chief Medical Officer |
|
2024-07-05 |
4 |
S |
$2.51 |
$6,207 |
D/D |
(2,475) |
159,312 |
0 |
% |
|
GTHX |
G1 Therapeutics Inc |
Chief Medical Officer |
|
2024-09-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(87,450) |
0 |
0 |
- |
|
GTHX |
G1 Therapeutics Inc |
Chief Medical Officer |
|
2024-09-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(89,762) |
87,450 |
0 |
- |
|
GTHX |
G1 Therapeutics Inc |
Chief Medical Officer |
|
2024-09-18 |
4 |
A |
$0.00 |
$0 |
D/D |
17,900 |
177,212 |
0 |
- |
|
66 Records found
|
|
Page 3 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|